secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIO-PATH HOLDINGS, INC. (BPTH)
CIK:        0001133818
Form:       8-K
Filed at:   2025-11-14T23:59:59+00:00
Accession:  0001663577-25-000317
Event type: other
Sentiment:  negative
Materiality: 0.70
Item codes: 5.02, 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Bio-Path warns of going concern doubt, seeks financing; director resigns
------------------------------------------------------------------------

- Director Douglas Morris resigned effective Nov 13, 2025; resignation received Nov 4.
- Company seeking financing to fund turnaround; plans to update finance team, engage new PCAOB auditors, hire investment bankers to review biotech portfolio for sale/partnership/M&A.
- Warns substantial doubt about ability to continue as going concern if capital raise fails; notes risk of delisting from OTC Markets.
- No specifics on financing amount or timeline; strategic review of portfolio and M&A pursuits announced.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1133818/000166357725000317/0001663577-25-000317-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1133818/000166357725000317/bpth_8k110425.htm
  HTML page:      https://secwatch.observer/filing/0001663577-25-000317

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer